Molecular Vaccines - From Prophylaxis to Therapy - Volume 2

This title discusses all aspects of non-infectious and non-cancer- so called NINC - vaccines. Hypertension, diabetes and allergy vaccine development are referred to as well as the use of adjuvants and nanotechnology in vaccine development. The way of novel vaccines from bench to preclinical to clinical studies and launch to the market under EMEA (European Medicines Agency) and FDA (Food and Drug Administration) guidelines are described in-depth. The book is therefore of interest for researchers and clinicians engaged in vaccine development and molecular vaccine application.

List of contents

Non-infectious and non-cancer vaccines.- Adjuvants and nanotechnology.- In silico and delivery systems.- Patenting, manufacturing, registration.

About the author

Dr. Matthias Giese, Heidelberg, Germany

Product details

• Assisted by: Matthia Giese (Editor), Matthias Giese (Editor)
• Publisher: Springer, Berlin
• Languages: English
• Product format: Paperback / Softback
• Released: 01.01.2016
• EAN: 9783319376752
• ISBN: 978-3-31-937675-2
• No. of pages: 423
• Dimensions: 178 mm x 20 mm x 254 mm
• Weight: 946 g
• Illustrations: XXVIII, 423 p. 98 illus., 74 illus. in color.
• Subjects: Natural sciences, medicine, IT, technology > Medicine > Pharmacy; B, Medical research, Immunology, Medizinische Forschung, molecular biology, Pharmacology, Vaccine, Biomedical and Life Sciences, Biomedical Research, Molecular Medicine, Vaccines